-
Alvotech, Cipla Gulf to commercialise key biosimilar in few emerging markets
biospectrumasia
July 29, 2019
For the commercialization of AVT02, an adalimumab biosimilar, in select emerging markets.
-
Biopharmaceutical contract manufacturing market expected to rise 10.6 percent
europeanpharmaceuticalreview
June 20, 2019
A study has predicted that the global biopharmaceutical contract manufacturing market will grow by 10.6 percent from 2017 to 2027.
-
Samsung BioLogics: A World Leader in Biopharmaceutical Manufacturing
fiercepharma
May 29, 2019
Biopharmaceutical outsourcing for research and development is expected to exceed revenues of $43 billion USD by 2026, as a growing number of pharmaceutical companies turn to independent contract development and manufacturing organizations (CDMOs) to bring
-
Takeda and Frazier team up to launch biopharmaceutical firm
pharmaceutical-technology
May 22, 2019
Takeda Pharmaceutical has collaborated with US-based Frazier Healthcare Partners to launch a biopharmaceutical company named Phathom Pharmaceuticals.
-
Investment Risks and Logic of the Bio-medicine Industry (2)
En-CPhI.cn
May 21, 2019
Characteristics of the bio-medicine industry decide that unique ideas should be employed to invest in the field...
-
Bristol-Myers Squibb reports first quarter financial results
April 26, 2019
Bristol-Myers Squibb Company (NYSE:BMY) today reported results for the first quarter of 2019 which were highlighted by s
-
Bio-Techne, Elpiscience Enter Strategic Anti-Cancer Alliance
b3cnewswire
April 23, 2019
Elpiscience will have access to multiple antibodies from Bio-Techne's product portfolio for use in the development of biopharmaceuticals...
-
AskBio secures $235m investment to accelerate growth
pharmaceutical-technology
April 23, 2019
Gene therapy company Asklepios BioPharmaceutical (AskBio) has received an investment of $225m from TPG Capital and Vida Ventures to accelerate its long-term growth.
-
Discover Roquette’s latest biopharmaceutical innovations and our 360° digital experience
europeanpharmaceuticalreview
April 18, 2019
Learn how Roquette supports customers in the development of innovative pharmaceutical formulations and new biopharma solutions…
-
AlzProtect Starts Collaboration with PAREXEL Biotech for Phase 2a of AZP2006 for the Treatment of Progressive Supranuclear Palsy (PSP)
b3cnewswire
April 17, 2019
AlzProtect Starts Collaboration with PAREXEL Biotech for Phase 2a of AZP2006 for the Treatment of Progressive Supranuclear Palsy (PSP)